EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of EDG004 compared to placebo for the treatment of adult patients
with GAD, diagnosed by Diagnostic and Statistical Manual of Mental Disorders, 5th Ed. (DSM-5)
and confirmed by the Mini International Neuropsychiatric Interview (MINI 7.0). Efficacy will
be measured by a statistically significant greater mean reduction from baseline compared to
endpoint in anxiety symptoms as measured by the total score of the clinician-rated Hamilton
Rating Scale for Anxiety (HAM-A) for the EDG004 treatment group compared to placebo.